|
Jul 24
|
Cosmo Achieves Robust Financial Performance in H1 2024 and Confirms Its Full Year Guidance
|
|
Jun 18
|
Cosmo's Oral Diagnostic Drug Lumeblue(R) Receives Approval of New Drug Application in China
|
|
May 31
|
Cosmo Reports Excellent Final Full Year 2023 Financial Results - Increases Operating Profit Guidance for 2024 - Dividend of 2.00 per Share Will Be Proposed at EGM on 5 July 2024
|
|
Dec 18
|
Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues Pushing Shares 37% Higher
|
|
Dec 13
|
Medtronic (MDT) Expands AI-Driven Care With New Partnership
|
|
Dec 11
|
Medtronic expands AI endoscopy partnership with Cosmo
|
|
Dec 11
|
Cosmo Pharmaceuticals and Medtronic Forge Ahead in AI-Driven Care
|